|
FBXO21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.923000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.197600E-01 |
| Normal-vs-Stage2 |
8.300000E-01 |
| Normal-vs-Stage3 |
3.649200E-01 |
| Normal-vs-Stage4 |
3.584400E-01 |
| Stage1-vs-Stage2 |
7.215800E-01 |
| Stage1-vs-Stage3 |
1.907200E-01 |
| Stage1-vs-Stage4 |
2.052200E-01 |
| Stage2-vs-Stage3 |
5.961200E-01 |
| Stage2-vs-Stage4 |
6.128000E-01 |
| Stage3-vs-Stage4 |
9.577000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.133000E-01 |
| Normal-vs-AfricanAmerican |
2.011200E-01 |
| Normal-vs-Asian |
3.485600E-01 |
| Caucasian-vs-AfricanAmerican |
1.479450E-01 |
| Caucasian-vs-Asian |
3.627800E-01 |
| AfricanAmerican-vs-Asian |
5.386200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.671400E-01 |
| Normal-vs-Female |
9.182400E-01 |
| Male-vs-Female |
3.522600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.991400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.629600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.442170E-01 |
| Normal-vs-Age(81-100Yrs) |
9.039800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.076600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.856000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.258570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.326100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.372440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.237600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.236400E-03 |
| Classical-VS-Follicular |
1.043650E-03 |
| Classical-VS-Other |
4.999800E-01 |
| Classical-VS-Normal |
4.650400E-01 |
| Tall-VS-Follicular |
9.163200E-01 |
| Tall-VS-Other |
6.572800E-01 |
| Tall-VS-Normal |
1.348220E-01 |
| Follicular-VS-Other |
6.918200E-01 |
| Follicular-VS-Normal |
9.433800E-02 |
| Other-VS-Normal |
6.927600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.719200E-01 |
| Normal-vs-N1 |
1.347020E-01 |
| N0-vs-N1 |
3.089600E-01 |
|
|
